Salivary lipid peroxidation and lipid profile levels in patients with recent ischemic stroke

Journal of International Dental and Medical Research

Volumn 3, Issue 2, 2010, Pages 57-64

  Al Rawi, Natheer H ^a  

^a UNIVERSITY OF SHARJAH   (United Arab Emirates)

Author keywords

Cholesterol; Dislipid; Lipid peroxidation; Lipids; Saliva; Triglycerides

Indexed keywords

EID: 80051596416     PISSN: 1309100X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Buckley BM. Lipids and Stroke. Br J Diab & Vas Dis 2003;3:170-6.
2. Gariballa SE, Hutchin TP, Sidair AJ. Antioxident capacity after acute ischemic stroke. QIM 2002;95:685-90.
3. Denti L, Cechetti A, Annoni V, Franceska M, Ablondi F, et al. The role of lipid profile in determining the risk of ischemic stroke in the elderly: a case- control study. Arch GeroontolGeriatr 2003;37:51-62.
4. Tirschwell DL, Smith NL, Heckbert SR, Lamaitre RN, Longstreth WT, etal. Association of cholesterol with stroke risk varies in stroke subtypes and patients subgroups. Neurology 2004;23:1868-75.
5. Muralikrishna A, Dibhatie R, Hetcher JF. Phospholipase A2, reactive oxygen species and lipid Peroxidation in cerebral ischemia. Free Radic Biol Med 2006;40:376-87.
6. Polidori MC, Frei B, Chimbini A, Nelles G, Rordorf G, Kearey JF, et al. Increased plasma levels of lipid hydroxyperoxidase in patients with ischemic stroke. Free Radic Biol Med 1998;25:561-7.
7. Uno M, Kitazato KT, Nishi K, Itabe H, Nagahiro S. Raised plasmaoxidized LDL in acute cerebral infarction. J Neurol Neurosurg Psychiatry 2003;74:312-7.
8. Cherubini A, Ruggiero C, Polidori MC, Mecocci P. Potential markers of oxidative stress on stroke. Free Radic Biol Med 2005;39:841-52.
9. Leinonen JS, Ahonen JP, Loennrot K, Jenkonen M, Destider P, Moinar G, et al. Plasma antioxidant capacity is associated with high lesion volume and neurological impairment in stroke. Stroke 2000;31:33-9.
10. Watson BD. Evaluation of the concomitance lipid Peroxidation in experimental model of cerebral ischemia and stroke. Prog Brain Res 1993;96:69-95.
11. Ferriti G, Bacchetti T, Masciangelo S, Nanetti L, Mazzanti L, Sivestrini M, et al. Lipid Peroxidation in stroke patients Clin Chem Lab Med 2008;46(1):113-17.
12. Yildirim A, Kotan D, Yildirim S, Aygol R, Akcay F. Increased lipid Peroxidation and decreased antioxidant response in serum and cerebrospinal fluid in acute ischemic stroke. Turk J Med Sci 2007;37(2):75-81.
13. Bhattachaejee J, Srivastava DK. Serum Malondialdehyde (MDA) in relation to lipidemic status and atherogenic index. Ind J Clin BioChem 1993;8(1):12-15.
14. Lawrence HP. Salivary markers of systemic disease: Non invasive diagnosis of disease and monitoring of general health. J Can Dent Assoc 2002;68(3):170-4.
15. Lu Y, Bently G, Gann P, Hodgesk K. Salivary estradiol and progesterone levels in conception and non-conception cycle in women: Evaluation of a new assay for salivary estradiol. Fertility & Sterility 1999;71(5):863-68.
16. Karajalainen S, Sewan L, Soderling E, Larsson B, Johansson I, et al. Salivary cholesterol of healthy adults in relation to serum cholesterol concentration and oral health. J Dent Res 1997;76:1637-43.
17. Buege JA, Aust SD. Microsomal lipid Peroxidation. Methods Enzymol 1978;52:302-310.
18. Richmond W. Preparation and properties of a cholesterol oxidase from Nocardia species and its application to the enzymatic assay of total cholesterol in serum. Clin Chem 1973;19:1350-6.
19. Fossati P, Prencipe L. Serum triglycerides determined calorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 1982;28:2077-80.
20. +2 polyethylene glycol precipitation, both with enzymatic cholesterol assay compared with the lipid research clinic method. Am J Clin Pathol 1982;78:718-23.
21. Friedwald WT, Levy RI, Fredrickson D. Estimation of the concentration of LDL-C in plasma without the use of preoperative ultracentrifuge. Clin Chem 1972;18(6):494-515.
22. Wang O, Tang XN, Yenari MA. The inflammatory response in stroke. J Neuroimmunol 2007;184:53-68.
23. Hermes-Lima M, Willmore WG, Story KB. Quantification of Lipid Peroxidation in Tissue Extracts Based on Fe (III) Xylenol Orange Complex Formation. Free Radic Biol Med 1995;19: 271-280.
24. Sakamoto A, Ohnishi ST, Ohnishi T & Ogawa R. Relationship between free radical production and lipid peroxidation during ischemia-reperfusion injury in rat brain. Brain Res 1991;554: 186-192.
25. Draper HH, Squires EJ, Mahmoodi H, Wu J, Agarwal S, Hadley M. A Comparative Evaluation of Thiobarbituric Acid Methods for the Determination of Malondialdehyde in Biological Materials. Free Radic Biol and Med 1993;15: 353-363.
26. Sharpe, P.C., Mulholland, C. & Trinick, T. Ascorbate and malondialdehyde in stroke patients. Ir J Med Sci 1994; 163: 488-491.
27. Atiyah KM, Al-Rawi NH. Evaluation of Salivary and Serum Oxidative Stress and Neuronal Damage Markers as Potential Parameters in Prediction of Ischemic Stroke from Stroke-Related Risk Factors. Ph.D Thesis. University of Baghdad.
28. Sacco RL, Bensen RT, Karagman DE. High-density lipoprotein cholesterol and ischemic stroke in the elderly. The Northern Manhattan Stroke study. JAMA 2001; 285:2729-2735.
29. Benfante R, Yano K, Hwang LJ, Curb JD, Kagan A, Ross W. Elevated serum cholesterol is a risk factor for both coronary heart diseases and thrombo-embolic stroke in Hawaiian Japanese men. Implications of shared risk. Stroke 1994;25:814-20.
30. Di Mascio R, Marchioli R, Vitullo F, Di Pasquale A, Cavasinni L, Tognoni G. Serum cholesterol and risk of ischemic stroke: results of a case control study. On behalf of PROGETTO3A investigators. Prev Med 1995; 24:124-133.
31. Ebrahim S, Sung J, Song YM, Ferrer RL, Lawlor DA, Davey Smith G. Serum cholesterol, hemorrhagic stroke, ischemic stroke and myocardial infarction:Korean National Health System Prospective Cohort Study. BMJ 2006:333:22.
32. Zhang X, Patel A, Horibe H et al. Cholestrol, Coronary heart disease and stroke in the Asia Pacific region. Int J Epidemiol 2003; 32:563-72.
33. Kagan A, Papper JS, Rhoods GG. Factors related to stroke incidence in Hawaii Japanese men. The Honolulu Heart study. Stroke 1980; 11:14-21.
34. Prospective studies collaboration. Cholesterol, diastolic blood pressure and stroke: 13,000 strokes in 450,000 people cohorts. Lancet 1995; 346:1647-53.
35. Bowman TS, Sesso HD, Ma J, et al. cholesterol and risk of ischemic stroke. Stroke 2003; 34:2930-34.
36. Shahar E, Chambles LE, Rasmond WD, Boland LL, Ballantyne CM, et al. Plasma lipid profile and incident ischemic stroke: The Atherosclerosis Risk in Communities (ARIC) study. Stroke 2003; 34:623-30.
37. Gorelick PB, Mazzone T. Plasma lipids and stroke. J Cardiovas Risk 1999; 6:217-21. (s)
38. Gordon DJ and Rifkind BM. High-density lipoproteins: The clinical implication of recent studies. N Eng J Med 1989; 321:1311-16.
39. Oizilbash N, Jones L, Warlow C, Mann J. Fibrinogen and lipid concentrations as risk factors for transient ischemic attacks and minor ischemic stroke. BMJ 1991; 303:605-609.
40. Sridharan R. Risk factors for ischemic stroke: A case control analysis. Neuroepidemiol 1992; 11:24-30.
41. Bihari-Varga M, Szekely J, Gruber E. Plasma high density lipoproteins in coronary, cerebral and peripheral vascular disease: The influence in coronary risk factors. Athersclerosis 1981; 40:337-45.
42. Koren- Morag N, Tanne D, Gralf E, Goldbourt U. low and high density lipoprotein cholesterol and ischemic cerebro vascular diseases: the Bezafibrate infarction prevention registry. Arch Intern Med 2002; 162:993-99.
43. Salonen JT and Puska P. Relation of serum cholesterol and triglycerides to the risk of acute MI, cerebral stroke and death in eastern Finnish male population. Int J Epidemiol 1982; 12(1):26-31.
44. Kurth T, Evert BM, Buring JE, Kase CS, Ridker PM, Gaziano JM. Lipid levels and the risk of ischemic in women. Neurology 2007; 68:556-62.
45. Gaziano JM, Buring JE, Breslow JL, et al. moderate alcohol intake, increased levels of high-density lipoproteins and its subfractions, and decreased risk of myocardial infarction. N Eng J Med 1993; 329:1829-34.
46. Ritschel WA, Thompson GA. Monitoring of drug concentrations in saliva: a non - invasive pharmacokinetic procedure. Methods and findings in Experimental and Clinical Pharmacology 1983; 5:511-25.